Shigeki Yagyu

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Histone Deacetylase

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Clinical & translational immunology

Molecular cancer therapeutics

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Shigeki Yagyu, Yozo Nakazawa
piggyBac-transposon-mediated CAR-T cells for the treatment of hematological and solid malignancies. International journal of clinical oncology (2023)
Satoshi Obu, Katsutsugu Umeda, Hiroo Ueno, Mari Sonoda, Keiji Tasaka, Hideto Ogata, Kagehiro Kouzuki, Seishiro Nodomi, Satoshi Saida, Itaru Kato, Hidefumi Hiramatsu, Tatsuya Okamoto, Eri Ogawa, Hideaki Okajima, Ken Morita, Yasuhiko Kamikubo, Koji Kawaguchi, Kenichiro Watanabe, Hideto Iwafuchi, Shigeki Yagyu, Tomoko Iehara, Hajime Hosoi, Tatsutoshi Nakahata, Souichi Adachi, Shinji Uemoto, Toshio Kitawaki, Junko Takita
CD146 is a potential immunotarget for neuroblastoma. Cancer science 112 (11) (2021)
Aiko Hasegawa, Shoji Saito, Shogo Narimatsu, Shigeru Nakano, Mika Nagai, Hideki Ohnota, Yoichi Inada, Hirokazu Morokawa, Ikumi Nakashima, Daisuke Morita, Yuichiro Ide, Kazuyuki Matsuda, Haruko Tashiro, Shigeki Yagyu, Miyuki Tanaka, Yozo Nakazawa
Mutated GM-CSF-based CAR-T cells targeting CD116/CD131 complexes exhibit enhanced anti-tumor effects against acute myeloid leukaemia. Clinical & translational immunology 10 (5) (2021)
Akimasa Tomida, Shigeki Yagyu, Kayoko Nakamura, Hiroshi Kubo, Kumiko Yamashima, Yozo Nakazawa, Hajime Hosoi, Tomoko Iehara
Inhibition of MEK pathway enhances the antitumor efficacy of chimeric antigen receptor T cells against neuroblastoma. Cancer science 112 (10) (2021)
Shigeki Yagyu, Hidemi Mochizuki, Kumiko Yamashima, Hiroshi Kubo, Shoji Saito, Miyuki Tanaka, Kengo Sakamoto, Akihito Shimoi, Yozo Nakazawa
A lymphodepleted non-human primate model for the assessment of acute on-target and off-tumor toxicity of human chimeric antigen receptor-T cells. Clinical & translational immunology 10 (6) (2021)
Hirokazu Morokawa, Shigeki Yagyu, Aiko Hasegawa, Miyuki Tanaka, Shoji Saito, Hidemi Mochizuki, Kengo Sakamoto, Akihito Shimoi, Yozo Nakazawa
Autologous non-human primate model for safety assessment of piggyBac transposon-mediated chimeric antigen receptor T cells on granulocyte-macrophage colony-stimulating factor receptor. Clinical & translational immunology 9 (11) (2020)
Yohei Sugimoto, Yoshiki Katsumi, Tomoko Iehara, Daisuke Kaneda, Chihiro Tomoyasu, Kazutaka Ouchi, Hideki Yoshida, Mitsuru Miyachi, Shigeki Yagyu, Ken Kikuchi, Kunihiko Tsuchiya, Yasumichi Kuwahara, Toshiyuki Sakai, Hajime Hosoi
The Novel Histone Deacetylase Inhibitor, OBP-801, Induces Apoptosis in Rhabdoid Tumors by Releasing the Silencing of NOXA. Molecular cancer therapeutics 19 (10) (2020)
Tomoko Iehara, Akihiro Yoneda, Isao Yokota, Hideto Takahashi, Satoshi Teramukai, Takehiko Kamijyo, Atsuko Nakazawa, Tetsuya Takimoto, Atsushi Kikuta, Shigeki Yagyu, Hitoshi Ikeda, Akira Nakagawara, Tatsuro Tajiri, null null
Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee. Pediatric blood & cancer 66 (11) (2019)